» Articles » PMID: 34118736

SARS-CoV-2 Infection During Pregnancy and Pregnancy-related Conditions: Concerns, Challenges, Management and Mitigation Strategies-a Narrative Review

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health problem. The SARS-CoV-2 triggers hyper-activation of inflammatory and immune responses resulting in cytokine storm and increased inflammatory responses on several organs like lungs, kidneys, intestine, and placenta. Although SARS-CoV-2 affects individuals of all age groups and physiological statuses, immune-compromised individuals such as pregnant women are considered as a highly vulnerable group. This review aims to raise the concerns of high risk of infection, morbidity and mortality of COVID-19 in pregnant women and provides critical reviews of pathophysiology and pathobiology of how SARS-CoV-2 infection potentially increases the severity and fatality during pregnancy. This article also provides a discussion of current evidence on vertical transmission of SARS-CoV-2 during pregnancy and breastfeeding. Lastly, guidelines on management, treatment, preventive, and mitigation strategies of SARS-CoV-2 infection during pregnancy and pregnancy-related conditions such as delivery and breastfeeding are discussed.

Citing Articles

Is domestic violence during COVID-19 in lactating women related to infantile colic? An important question.

Simbar M, Kiani Z, Shaterian N, Bidgoli M, Shaterian N, Bayani G BMC Public Health. 2024; 24(1):2902.

PMID: 39434069 PMC: 11492789. DOI: 10.1186/s12889-024-20377-0.


Development and Validation of a Highly Sensitive RT-qLAMP Assay for Rapid Detection of SARS-CoV-2: Methodological Aspects.

Mahmoudi F, Jafari D, Esfahani S, Hoseini A, Barati M, Saraygord-Afshari N Mol Biotechnol. 2024; .

PMID: 39316362 DOI: 10.1007/s12033-024-01275-7.


Diabetes and susceptibility to COVID-19: Risk factors and preventive and therapeutic strategies.

Liu J, Huang X, Wang M, Yang J World J Diabetes. 2024; 15(8):1663-1671.

PMID: 39192862 PMC: 11346102. DOI: 10.4239/wjd.v15.i8.1663.


Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents.

Maikhunthod B, Chaipayang S, Jittmittraphap A, Thippornchai N, Boonchuen P, Tittabutr P BMC Complement Med Ther. 2024; 24(1):274.

PMID: 39030504 PMC: 11264683. DOI: 10.1186/s12906-024-04586-z.


The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative Review.

Al-Bdairi A, Makki H, Shawki O, Alkhudair S, Al-Hilli N, Alkhalidi B Cureus. 2024; 16(4):e57944.

PMID: 38738039 PMC: 11082527. DOI: 10.7759/cureus.57944.


References
1.
Narang K, Ibirogba E, Elrefaei A, Teles Abrao Trad A, Theiler R, Nomura R . SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines. J Clin Med. 2020; 9(5). PMC: 7291307. DOI: 10.3390/jcm9051521. View

2.
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y . Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034. PMC: 7184337. DOI: 10.1093/cid/ciaa344. View

3.
Bende M, Gredmark T . Nasal stuffiness during pregnancy. Laryngoscope. 1999; 109(7 Pt 1):1108-10. DOI: 10.1097/00005537-199907000-00018. View

4.
Akgor U, Fadiloglu E, Soyak B, Unal C, Cagan M, Temiz B . Anxiety, depression and concerns of pregnant women during the COVID-19 pandemic. Arch Gynecol Obstet. 2021; 304(1):125-130. PMC: 7802427. DOI: 10.1007/s00404-020-05944-1. View

5.
Lam C, Wong S, Leung T, Chow K, Yu W, Wong T . A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome. BJOG. 2004; 111(8):771-4. PMC: 7161819. DOI: 10.1111/j.1471-0528.2004.00199.x. View